Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

29.57USD
1:30am IST
Change (% chg)

$0.05 (+0.17%)
Prev Close
$29.52
Open
$29.52
Day's High
$29.60
Day's Low
$29.37
Volume
614,349
Avg. Vol
1,425,547
52-wk High
$29.60
52-wk Low
$19.67

Chart for

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $40,477.75
Shares Outstanding(Mil.): 1,372.13
Dividend: --
Yield (%): --

Financials

BRIEF-Boston Scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary

* Boston scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary Source text for Eikon: Further company coverage:

04 Oct 2017

BRIEF-Boston Scientific to buy Apama Medical

* Boston Scientific announces agreement to acquire Apama Medical

03 Oct 2017

BRIEF-Boston Scientific announces positive late-breaking clinical trial data for Heartlogic Heart Failure Diagnostic

* Boston Scientific announces positive late-breaking clinical trial data for the Heartlogic Heart Failure Diagnostic Source text for Eikon: Further company coverage:

19 Sep 2017

BRIEF-Veniti Inc announces Boston Scientific distribution agreement for VICI VENOUS STENT

* ‍Veniti Inc -Boston Scientific will distribute VICI VENOUS STENT under limited global distribution agreement; terms of agreement, specific regions, countries involved were not disclosed​ Source text for Eikon:

11 Sep 2017

BRIEF-Boston Scientific Corp says entered into a $2.25 bln senior unsecured credit facility- SEC Filing

* Boston Scientific Corp - on August 4, 2017, Boston Scientific Corporation entered into a $2.25 billion senior unsecured credit facility

08 Aug 2017

UPDATE 2-Boston Scientific beats profit estimates, raises forecast

July 27 Boston Scientific Corp on Thursday reported better-than-expected quarterly profit and revenue as the U.S. medical device maker benefited from strong demand across its businesses, which also helped the company raise full-year expectations.

27 Jul 2017

Boston Scientific posts profit in second quarter

July 27 Medical device maker Boston Scientific Corp on Thursday posted a profit in the second quarter compared with a year-ago loss, helped by higher sales as well as lower litigation-related expenses.

27 Jul 2017

BRIEF-Boston Scientific outlines strategy for sustained growth at 2017 investor day

* Boston Scientific outlines strategy for sustained growth at 2017 investor day

27 Jun 2017

EXCLUSIVE: India regulator wants medical devices added to price control list, document shows

NEW DELHI/MUMBAI India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country's $5 billion-a-year medical-technology industry.

07 Jun 2017

Exclusive - India regulator wants medical devices added to price control list, document shows

NEW DELHI/MUMBAI India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country's $5 billion-a-year medical-technology industry.

07 Jun 2017

Competitors

Earnings vs. Estimates